Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism |
| |
Authors: | Alenza Dolores Perez Arenas Carolina Lopez Mari Luz Melian Carlos |
| |
Affiliation: | Veterinary Teaching Hospital, Veterinary School, Complutense University of Madrid, Madrid, Spain. |
| |
Abstract: | Trilostane is considered an efficacious and safe medication for canine pituitary-dependent hyperadrenocorticism (PDH). Its recommended frequency of administration is once daily. In this prospective study, the efficacy, toxicity, and long-term outcome of trilostane administered twice daily per os were evaluated in 44 dogs with PDH. Mean initial dose was 3.1 mg/kg q 12 hours, and mean final dose was 3.2 mg/kg q 12 hours. The final total daily dose was lower than previously reported for once-daily administration. The mean survival time for affected dogs was 930 days. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|